TESMEC SPA (TES.MI) Fundamental Analysis & Valuation

BIT:TES • IT0004585243

Current stock price

0.128 EUR
-0.01 (-5.74%)
Last:

This TES.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. TES.MI Profitability Analysis

1.1 Basic Checks

  • In the past year TES has reported negative net income.
  • TES had a positive operating cash flow in the past year.
  • In multiple years TES reported negative net income over the last 5 years.
  • In the past 5 years TES always reported a positive cash flow from operatings.
TES.MI Yearly Net Income VS EBIT VS OCF VS FCFTES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

1.2 Ratios

  • The Return On Assets of TES (-0.63%) is worse than 71.96% of its industry peers.
  • The Return On Equity of TES (-3.71%) is worse than 72.90% of its industry peers.
  • TES has a better Return On Invested Capital (9.59%) than 82.24% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TES is below the industry average of 8.73%.
  • The 3 year average ROIC (5.59%) for TES is below the current ROIC(9.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.63%
ROE -3.71%
ROIC 9.59%
ROA(3y)0.01%
ROA(5y)-0.3%
ROE(3y)-0.38%
ROE(5y)-1.87%
ROIC(3y)5.59%
ROIC(5y)N/A
TES.MI Yearly ROA, ROE, ROICTES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

  • The Operating Margin of TES (9.57%) is better than 71.03% of its industry peers.
  • TES's Operating Margin has improved in the last couple of years.
  • TES has a Gross Margin (35.43%) which is in line with its industry peers.
  • TES's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.57%
PM (TTM) N/A
GM 35.43%
OM growth 3Y55.44%
OM growth 5Y15.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.55%
GM growth 5Y1.81%
TES.MI Yearly Profit, Operating, Gross MarginsTES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1

2. TES.MI Health Analysis

2.1 Basic Checks

  • TES has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, TES has about the same amount of shares outstanding.
  • Compared to 5 years ago, TES has more shares outstanding
  • Compared to 1 year ago, TES has an improved debt to assets ratio.
TES.MI Yearly Shares OutstandingTES.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
TES.MI Yearly Total Debt VS Total AssetsTES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • TES has an Altman-Z score of 1.05. This is a bad value and indicates that TES is not financially healthy and even has some risk of bankruptcy.
  • TES's Altman-Z score of 1.05 is on the low side compared to the rest of the industry. TES is outperformed by 72.90% of its industry peers.
  • The Debt to FCF ratio of TES is 46.07, which is on the high side as it means it would take TES, 46.07 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 46.07, TES is not doing good in the industry: 72.90% of the companies in the same industry are doing better.
  • TES has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
  • TES has a worse Debt to Equity ratio (1.16) than 80.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 46.07
Altman-Z 1.05
ROIC/WACC1.09
WACC8.77%
TES.MI Yearly LT Debt VS Equity VS FCFTES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 1.11 indicates that TES should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.11, TES is not doing good in the industry: 73.83% of the companies in the same industry are doing better.
  • TES has a Quick Ratio of 1.11. This is a bad value and indicates that TES is not financially healthy enough and could expect problems in meeting its short term obligations.
  • TES has a worse Quick ratio (0.51) than 87.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.51
TES.MI Yearly Current Assets VS Current LiabilitesTES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. TES.MI Growth Analysis

3.1 Past

  • TES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 209.09%, which is quite impressive.
  • The Revenue has decreased by -2.77% in the past year.
  • Measured over the past years, TES shows a small growth in Revenue. The Revenue has been growing by 3.61% on average per year.
EPS 1Y (TTM)209.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.69%
Revenue 1Y (TTM)-2.77%
Revenue growth 3Y7.23%
Revenue growth 5Y3.61%
Sales Q2Q%3.55%

3.2 Future

  • The Earnings Per Share is expected to grow by 72.25% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, TES will show a small growth in Revenue. The Revenue will grow by 6.33% on average per year.
EPS Next Y211.11%
EPS Next 2Y102.76%
EPS Next 3Y72.26%
EPS Next 5YN/A
Revenue Next Year2.81%
Revenue Next 2Y5.41%
Revenue Next 3Y6.33%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TES.MI Yearly Revenue VS EstimatesTES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
TES.MI Yearly EPS VS EstimatesTES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2020 2022 2023 2024 2025 2026 2027 0 0.01 0.02 0.03

6

4. TES.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Forward Earnings ratio is 6.67, which indicates a rather cheap valuation of TES.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TES indicates a rather cheap valuation: TES is cheaper than 92.52% of the companies listed in the same industry.
  • TES's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.12.
Industry RankSector Rank
PE N/A
Fwd PE 6.67
TES.MI Price Earnings VS Forward Price EarningsTES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 82.24% of the companies in the same industry are more expensive than TES, based on the Enterprise Value to EBITDA ratio.
  • TES's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.64
EV/EBITDA 5.47
TES.MI Per share dataTES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

  • TES's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as TES's earnings are expected to grow with 72.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y102.76%
EPS Next 3Y72.26%

0

5. TES.MI Dividend Analysis

5.1 Amount

  • TES does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TES.MI Fundamentals: All Metrics, Ratios and Statistics

TESMEC SPA

BIT:TES (3/18/2026, 3:20:31 PM)

0.128

-0.01 (-5.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-11
Earnings (Next)N/A
Inst Owners1.53%
Inst Owner ChangeN/A
Ins Owners4.78%
Ins Owner ChangeN/A
Market Cap77.63M
Revenue(TTM)243.90M
Net Income(TTM)-2.63M
Analysts80
Price Target0.17 (32.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.67
P/S 0.32
P/FCF 19.64
P/OCF 2.95
P/B 1.09
P/tB 2.78
EV/EBITDA 5.47
EPS(TTM)0
EYN/A
EPS(NY)0.02
Fwd EY14.99%
FCF(TTM)0.01
FCFY5.09%
OCF(TTM)0.04
OCFY33.89%
SpS0.4
BVpS0.12
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.63%
ROE -3.71%
ROCE 13.07%
ROIC 9.59%
ROICexc 11.26%
ROICexgc 15.58%
OM 9.57%
PM (TTM) N/A
GM 35.43%
FCFM 1.62%
ROA(3y)0.01%
ROA(5y)-0.3%
ROE(3y)-0.38%
ROE(5y)-1.87%
ROIC(3y)5.59%
ROIC(5y)N/A
ROICexc(3y)7.05%
ROICexc(5y)N/A
ROICexgc(3y)9.21%
ROICexgc(5y)N/A
ROCE(3y)7.56%
ROCE(5y)N/A
ROICexgc growth 3Y70.51%
ROICexgc growth 5Y11.87%
ROICexc growth 3Y63.57%
ROICexc growth 5Y10.04%
OM growth 3Y55.44%
OM growth 5Y15.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.55%
GM growth 5Y1.81%
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 46.07
Debt/EBITDA 1.93
Cap/Depr 116.42%
Cap/Sales 9.17%
Interest Coverage 1.36
Cash Conversion 61.85%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.51
Altman-Z 1.05
F-Score4
WACC8.77%
ROIC/WACC1.09
Cap/Depr(3y)161.13%
Cap/Depr(5y)148.44%
Cap/Sales(3y)14.73%
Cap/Sales(5y)15.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)209.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.69%
EPS Next Y211.11%
EPS Next 2Y102.76%
EPS Next 3Y72.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.77%
Revenue growth 3Y7.23%
Revenue growth 5Y3.61%
Sales Q2Q%3.55%
Revenue Next Year2.81%
Revenue Next 2Y5.41%
Revenue Next 3Y6.33%
Revenue Next 5YN/A
EBIT growth 1Y62.31%
EBIT growth 3Y66.68%
EBIT growth 5Y19.8%
EBIT Next Year214.29%
EBIT Next 3Y60.61%
EBIT Next 5YN/A
FCF growth 1Y125.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.55%
OCF growth 3Y-16.98%
OCF growth 5YN/A

TESMEC SPA / TES.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TESMEC SPA (TES.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TES.MI.


Can you provide the valuation status for TESMEC SPA?

ChartMill assigns a valuation rating of 5 / 10 to TESMEC SPA (TES.MI). This can be considered as Fairly Valued.


How profitable is TESMEC SPA (TES.MI) stock?

TESMEC SPA (TES.MI) has a profitability rating of 4 / 10.


Is the dividend of TESMEC SPA sustainable?

The dividend rating of TESMEC SPA (TES.MI) is 0 / 10 and the dividend payout ratio is 0%.